Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Melanoma 1Malignant Solid Neoplasm 1Malignant Primary Pelvic Neoplasm 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Heart Defects, Congenital 1Fatigue 1Depression 1Colonic Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1Carcinoma, Merkel Cell 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 6avelumab 6Nivolumab 5Specimen Handling 4Magnetic Resonance Spectroscopy 3Biopsy 3prednylidene 2lutetium Lu 177 dotatate 2deltacortene 2Prednisone 2Ipilimumab 2CTLA-4 Antigen 2talimogene laherparepvec 1lenvatinib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1cemiplimab 1aldesleukin 1Tacrolimus 1Sirolimus 1Saline Solution 1Radiotherapy 1Radiosurgery 1MAPRE1 protein, human 1Lutetium-177 1Laparoscopy 1Exercise Test 1Cyclophosphamide 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Merkel Cell × Exercise Test × 90 days × Clear all
NCT06008977 2026-03-25

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Active not recruiting
12 enrolled
Dermatologic

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡